Plain-English translation of NCT07009860 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a research study testing a medication called to see if it can help treat liver disease caused by heavy alcohol use. Half of participants will receive the real medication as a weekly injection, while the other half will receive a placebo (a dummy injection with no active medicine). The study will measure whether this treatment helps improve liver health and is safe to use.
Alcohol-related liver disease is a serious condition, and currently there are limited treatment options that directly target the liver damage it causes. This study aims to find out whether this new medication could help repair liver tissue and improve outcomes for people struggling with heavy alcohol use.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the new medication or a placebo as a weekly injection that you or a nurse can give you. You will visit the study clinic regularly so researchers can check your liver health through blood tests and special ultrasound imaging. The study involves about 100 people at multiple medical centers, and your participation will help determine whether this new treatment is safe and effective for liver disease caused by alcohol use.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States